nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolbutamide—SLCO1A2—Methotrexate—urinary bladder cancer	0.103	0.258	CbGbCtD
Tolbutamide—CYP2C8—Fluorouracil—urinary bladder cancer	0.0745	0.187	CbGbCtD
Tolbutamide—SLC22A6—Methotrexate—urinary bladder cancer	0.0624	0.157	CbGbCtD
Tolbutamide—CYP2C8—Etoposide—urinary bladder cancer	0.0622	0.156	CbGbCtD
Tolbutamide—CYP2C9—Fluorouracil—urinary bladder cancer	0.052	0.131	CbGbCtD
Tolbutamide—ABCC8—penis—urinary bladder cancer	0.0486	0.194	CbGeAlD
Tolbutamide—CYP2C9—Cisplatin—urinary bladder cancer	0.0441	0.111	CbGbCtD
Tolbutamide—CYP2C19—urine—urinary bladder cancer	0.0187	0.0746	CbGeAlD
Tolbutamide—CYP2C9—urine—urinary bladder cancer	0.0145	0.0578	CbGeAlD
Tolbutamide—KCNJ1—renal system—urinary bladder cancer	0.0142	0.0567	CbGeAlD
Tolbutamide—ABCC8—prostate gland—urinary bladder cancer	0.0116	0.0464	CbGeAlD
Tolbutamide—ABCC8—seminal vesicle—urinary bladder cancer	0.00982	0.0393	CbGeAlD
Tolbutamide—SLCO2B1—prostate gland—urinary bladder cancer	0.00909	0.0364	CbGeAlD
Tolbutamide—ABCC8—smooth muscle tissue—urinary bladder cancer	0.00822	0.0329	CbGeAlD
Tolbutamide—SLC15A1—epithelium—urinary bladder cancer	0.00816	0.0326	CbGeAlD
Tolbutamide—ABCC8—renal system—urinary bladder cancer	0.00792	0.0317	CbGeAlD
Tolbutamide—CYP2C18—vagina—urinary bladder cancer	0.00778	0.0311	CbGeAlD
Tolbutamide—SLC15A1—renal system—urinary bladder cancer	0.00757	0.0303	CbGeAlD
Tolbutamide—SLC15A2—prostate gland—urinary bladder cancer	0.00694	0.0278	CbGeAlD
Tolbutamide—KCNJ11—female reproductive system—urinary bladder cancer	0.00688	0.0275	CbGeAlD
Tolbutamide—Eruption—Gemcitabine—urinary bladder cancer	0.0063	0.0338	CcSEcCtD
Tolbutamide—Inappropriate antidiuretic hormone secretion—Cisplatin—urinary bladder cancer	0.00622	0.0333	CcSEcCtD
Tolbutamide—SLCO2B1—renal system—urinary bladder cancer	0.0062	0.0248	CbGeAlD
Tolbutamide—Reaction gastrointestinal—Methotrexate—urinary bladder cancer	0.00594	0.0318	CcSEcCtD
Tolbutamide—SLC15A2—seminal vesicle—urinary bladder cancer	0.00587	0.0235	CbGeAlD
Tolbutamide—SLCO1A2—renal system—urinary bladder cancer	0.0057	0.0228	CbGeAlD
Tolbutamide—Heartburn—Fluorouracil—urinary bladder cancer	0.00554	0.0297	CcSEcCtD
Tolbutamide—SLC15A1—vagina—urinary bladder cancer	0.00548	0.0219	CbGeAlD
Tolbutamide—Glipizide—PPARG—urinary bladder cancer	0.00547	1	CrCbGaD
Tolbutamide—Pancytopenia—Mitomycin—urinary bladder cancer	0.00546	0.0293	CcSEcCtD
Tolbutamide—SLCO2B1—female reproductive system—urinary bladder cancer	0.00496	0.0198	CbGeAlD
Tolbutamide—SLC15A2—renal system—urinary bladder cancer	0.00473	0.0189	CbGeAlD
Tolbutamide—SLC15A2—urethra—urinary bladder cancer	0.00465	0.0186	CbGeAlD
Tolbutamide—KCNJ11—lymph node—urinary bladder cancer	0.00403	0.0161	CbGeAlD
Tolbutamide—Erythema—Mitomycin—urinary bladder cancer	0.00401	0.0215	CcSEcCtD
Tolbutamide—CYP2C8—renal system—urinary bladder cancer	0.00398	0.0159	CbGeAlD
Tolbutamide—SLC15A2—female reproductive system—urinary bladder cancer	0.00379	0.0152	CbGeAlD
Tolbutamide—Leukopenia—Mitomycin—urinary bladder cancer	0.00359	0.0192	CcSEcCtD
Tolbutamide—SLC15A2—vagina—urinary bladder cancer	0.00343	0.0137	CbGeAlD
Tolbutamide—Pruritus—Valrubicin—urinary bladder cancer	0.00336	0.018	CcSEcCtD
Tolbutamide—CYP2C19—vagina—urinary bladder cancer	0.00331	0.0132	CbGeAlD
Tolbutamide—Eruption—Methotrexate—urinary bladder cancer	0.00322	0.0173	CcSEcCtD
Tolbutamide—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.0032	0.0172	CcSEcCtD
Tolbutamide—CYP2C8—female reproductive system—urinary bladder cancer	0.00319	0.0128	CbGeAlD
Tolbutamide—Eruption—Epirubicin—urinary bladder cancer	0.00302	0.0162	CcSEcCtD
Tolbutamide—Rash—Valrubicin—urinary bladder cancer	0.00299	0.016	CcSEcCtD
Tolbutamide—Headache—Valrubicin—urinary bladder cancer	0.00297	0.0159	CcSEcCtD
Tolbutamide—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.0029	0.0156	CcSEcCtD
Tolbutamide—SLCO2B1—lymph node—urinary bladder cancer	0.0029	0.0116	CbGeAlD
Tolbutamide—CYP2C8—vagina—urinary bladder cancer	0.00289	0.0115	CbGeAlD
Tolbutamide—CYP2C9—female reproductive system—urinary bladder cancer	0.00283	0.0113	CbGeAlD
Tolbutamide—Nausea—Valrubicin—urinary bladder cancer	0.00282	0.0151	CcSEcCtD
Tolbutamide—Eruption—Doxorubicin—urinary bladder cancer	0.00279	0.015	CcSEcCtD
Tolbutamide—Pancytopenia—Thiotepa—urinary bladder cancer	0.00275	0.0147	CcSEcCtD
Tolbutamide—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00263	0.0141	CcSEcCtD
Tolbutamide—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00241	0.0129	CcSEcCtD
Tolbutamide—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00231	0.0124	CcSEcCtD
Tolbutamide—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00227	0.0122	CcSEcCtD
Tolbutamide—SLC15A2—lymph node—urinary bladder cancer	0.00222	0.00886	CbGeAlD
Tolbutamide—Photosensitivity reaction—Fluorouracil—urinary bladder cancer	0.00218	0.0117	CcSEcCtD
Tolbutamide—Pancytopenia—Cisplatin—urinary bladder cancer	0.00215	0.0115	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Epirubicin—urinary bladder cancer	0.00211	0.0113	CcSEcCtD
Tolbutamide—Rash—Mitomycin—urinary bladder cancer	0.00206	0.0111	CcSEcCtD
Tolbutamide—Headache—Mitomycin—urinary bladder cancer	0.00205	0.011	CcSEcCtD
Tolbutamide—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00202	0.0108	CcSEcCtD
Tolbutamide—Erythema—Thiotepa—urinary bladder cancer	0.00201	0.0108	CcSEcCtD
Tolbutamide—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00199	0.0107	CcSEcCtD
Tolbutamide—Pancytopenia—Etoposide—urinary bladder cancer	0.00197	0.0106	CcSEcCtD
Tolbutamide—Jaundice cholestatic—Doxorubicin—urinary bladder cancer	0.00195	0.0105	CcSEcCtD
Tolbutamide—Nausea—Mitomycin—urinary bladder cancer	0.00194	0.0104	CcSEcCtD
Tolbutamide—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00186	0.00998	CcSEcCtD
Tolbutamide—Leukopenia—Thiotepa—urinary bladder cancer	0.0018	0.00967	CcSEcCtD
Tolbutamide—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00174	0.00934	CcSEcCtD
Tolbutamide—Agranulocytosis—Etoposide—urinary bladder cancer	0.00173	0.00926	CcSEcCtD
Tolbutamide—Erythema—Gemcitabine—urinary bladder cancer	0.00169	0.00908	CcSEcCtD
Tolbutamide—Erythema—Fluorouracil—urinary bladder cancer	0.00167	0.00893	CcSEcCtD
Tolbutamide—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00161	0.00864	CcSEcCtD
Tolbutamide—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00161	0.00863	CcSEcCtD
Tolbutamide—Erythema—Cisplatin—urinary bladder cancer	0.00158	0.00847	CcSEcCtD
Tolbutamide—Leukopenia—Gemcitabine—urinary bladder cancer	0.00152	0.00813	CcSEcCtD
Tolbutamide—Leukopenia—Fluorouracil—urinary bladder cancer	0.00149	0.008	CcSEcCtD
Tolbutamide—Dyspepsia—Thiotepa—urinary bladder cancer	0.00145	0.00776	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00142	0.00761	CcSEcCtD
Tolbutamide—Leukopenia—Cisplatin—urinary bladder cancer	0.00141	0.00758	CcSEcCtD
Tolbutamide—Hypoglycaemia—Epirubicin—urinary bladder cancer	0.00138	0.0074	CcSEcCtD
Tolbutamide—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00135	0.00726	CcSEcCtD
Tolbutamide—Hyponatraemia—Epirubicin—urinary bladder cancer	0.00135	0.00725	CcSEcCtD
Tolbutamide—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00133	0.00714	CcSEcCtD
Tolbutamide—Urticaria—Thiotepa—urinary bladder cancer	0.00131	0.007	CcSEcCtD
Tolbutamide—Leukopenia—Etoposide—urinary bladder cancer	0.0013	0.00694	CcSEcCtD
Tolbutamide—Hypoglycaemia—Doxorubicin—urinary bladder cancer	0.00128	0.00685	CcSEcCtD
Tolbutamide—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00126	0.00677	CcSEcCtD
Tolbutamide—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00125	0.00671	CcSEcCtD
Tolbutamide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.0012	0.00642	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00119	0.0064	CcSEcCtD
Tolbutamide—Pancytopenia—Methotrexate—urinary bladder cancer	0.00118	0.00633	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00117	0.00629	CcSEcCtD
Tolbutamide—Abdominal distension—Epirubicin—urinary bladder cancer	0.00117	0.00628	CcSEcCtD
Tolbutamide—Pruritus—Thiotepa—urinary bladder cancer	0.00116	0.00624	CcSEcCtD
Tolbutamide—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00116	0.0062	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Methotrexate—urinary bladder cancer	0.00114	0.00609	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00111	0.00597	CcSEcCtD
Tolbutamide—Pancytopenia—Epirubicin—urinary bladder cancer	0.00111	0.00593	CcSEcCtD
Tolbutamide—Abdominal distension—Doxorubicin—urinary bladder cancer	0.00108	0.00581	CcSEcCtD
Tolbutamide—Urticaria—Fluorouracil—urinary bladder cancer	0.00108	0.00579	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.00106	0.0057	CcSEcCtD
Tolbutamide—Rash—Thiotepa—urinary bladder cancer	0.00104	0.00556	CcSEcCtD
Tolbutamide—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00103	0.00555	CcSEcCtD
Tolbutamide—Headache—Thiotepa—urinary bladder cancer	0.00103	0.00552	CcSEcCtD
Tolbutamide—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00102	0.00548	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00102	0.00547	CcSEcCtD
Tolbutamide—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000983	0.00527	CcSEcCtD
Tolbutamide—Pruritus—Gemcitabine—urinary bladder cancer	0.000978	0.00525	CcSEcCtD
Tolbutamide—Nausea—Thiotepa—urinary bladder cancer	0.000976	0.00524	CcSEcCtD
Tolbutamide—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000969	0.00519	CcSEcCtD
Tolbutamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000962	0.00516	CcSEcCtD
Tolbutamide—Urticaria—Etoposide—urinary bladder cancer	0.000938	0.00503	CcSEcCtD
Tolbutamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000896	0.0048	CcSEcCtD
Tolbutamide—Rash—Gemcitabine—urinary bladder cancer	0.000872	0.00467	CcSEcCtD
Tolbutamide—Erythema—Methotrexate—urinary bladder cancer	0.000867	0.00465	CcSEcCtD
Tolbutamide—Headache—Gemcitabine—urinary bladder cancer	0.000866	0.00464	CcSEcCtD
Tolbutamide—Rash—Fluorouracil—urinary bladder cancer	0.000857	0.0046	CcSEcCtD
Tolbutamide—Headache—Fluorouracil—urinary bladder cancer	0.000852	0.00457	CcSEcCtD
Tolbutamide—Pruritus—Etoposide—urinary bladder cancer	0.000835	0.00448	CcSEcCtD
Tolbutamide—Nausea—Gemcitabine—urinary bladder cancer	0.000821	0.0044	CcSEcCtD
Tolbutamide—Rash—Cisplatin—urinary bladder cancer	0.000813	0.00436	CcSEcCtD
Tolbutamide—Erythema—Epirubicin—urinary bladder cancer	0.000811	0.00435	CcSEcCtD
Tolbutamide—Nausea—Fluorouracil—urinary bladder cancer	0.000808	0.00433	CcSEcCtD
Tolbutamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000776	0.00416	CcSEcCtD
Tolbutamide—Nausea—Cisplatin—urinary bladder cancer	0.000766	0.00411	CcSEcCtD
Tolbutamide—Erythema—Doxorubicin—urinary bladder cancer	0.00075	0.00402	CcSEcCtD
Tolbutamide—Rash—Etoposide—urinary bladder cancer	0.000745	0.00399	CcSEcCtD
Tolbutamide—Headache—Etoposide—urinary bladder cancer	0.00074	0.00397	CcSEcCtD
Tolbutamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000726	0.00389	CcSEcCtD
Tolbutamide—Nausea—Etoposide—urinary bladder cancer	0.000701	0.00376	CcSEcCtD
Tolbutamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000693	0.00371	CcSEcCtD
Tolbutamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000672	0.0036	CcSEcCtD
Tolbutamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000648	0.00347	CcSEcCtD
Tolbutamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000623	0.00334	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000611	0.00327	CcSEcCtD
Tolbutamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.0006	0.00322	CcSEcCtD
Tolbutamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000583	0.00312	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000571	0.00306	CcSEcCtD
Tolbutamide—Urticaria—Methotrexate—urinary bladder cancer	0.000562	0.00301	CcSEcCtD
Tolbutamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000539	0.00289	CcSEcCtD
Tolbutamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000529	0.00284	CcSEcCtD
Tolbutamide—Urticaria—Epirubicin—urinary bladder cancer	0.000526	0.00282	CcSEcCtD
Tolbutamide—Pruritus—Methotrexate—urinary bladder cancer	0.0005	0.00268	CcSEcCtD
Tolbutamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000487	0.00261	CcSEcCtD
Tolbutamide—Pruritus—Epirubicin—urinary bladder cancer	0.000468	0.00251	CcSEcCtD
Tolbutamide—Rash—Methotrexate—urinary bladder cancer	0.000446	0.00239	CcSEcCtD
Tolbutamide—Headache—Methotrexate—urinary bladder cancer	0.000443	0.00238	CcSEcCtD
Tolbutamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000433	0.00232	CcSEcCtD
Tolbutamide—Nausea—Methotrexate—urinary bladder cancer	0.00042	0.00225	CcSEcCtD
Tolbutamide—Rash—Epirubicin—urinary bladder cancer	0.000417	0.00224	CcSEcCtD
Tolbutamide—Headache—Epirubicin—urinary bladder cancer	0.000415	0.00222	CcSEcCtD
Tolbutamide—Nausea—Epirubicin—urinary bladder cancer	0.000393	0.00211	CcSEcCtD
Tolbutamide—Rash—Doxorubicin—urinary bladder cancer	0.000386	0.00207	CcSEcCtD
Tolbutamide—Headache—Doxorubicin—urinary bladder cancer	0.000384	0.00206	CcSEcCtD
Tolbutamide—Nausea—Doxorubicin—urinary bladder cancer	0.000364	0.00195	CcSEcCtD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000351	0.0022	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—UGT2B7—urinary bladder cancer	0.000341	0.00213	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000327	0.00204	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000325	0.00203	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00032	0.002	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000319	0.002	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000319	0.002	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CYP4B1—urinary bladder cancer	0.000316	0.00198	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTZ1—urinary bladder cancer	0.000316	0.00197	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.00031	0.00194	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CYP4B1—urinary bladder cancer	0.000307	0.00192	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.0003	0.00188	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTO2—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NAT1—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—SLC19A1—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Tolbutamide—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000299	0.00187	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000294	0.00184	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PRSS3—urinary bladder cancer	0.000291	0.00182	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—SLC19A1—urinary bladder cancer	0.00029	0.00181	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000285	0.00178	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PRSS3—urinary bladder cancer	0.000282	0.00177	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000276	0.00173	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—UGT2B7—urinary bladder cancer	0.000274	0.00171	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000273	0.00171	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000267	0.00167	CbGpPWpGaD
Tolbutamide—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000267	0.00167	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00026	0.00162	CbGpPWpGaD
Tolbutamide—KCNJ1—Neuronal System—HRAS—urinary bladder cancer	0.000259	0.00162	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	0.000254	0.00159	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	0.000254	0.00159	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000252	0.00158	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000249	0.00156	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CYP4B1—urinary bladder cancer	0.000247	0.00154	CbGpPWpGaD
Tolbutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000243	0.00152	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TYMP—urinary bladder cancer	0.000233	0.00146	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—SLC19A1—urinary bladder cancer	0.000233	0.00146	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	0.000232	0.00145	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00023	0.00144	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PRSS3—urinary bladder cancer	0.000227	0.00142	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TYMP—urinary bladder cancer	0.000226	0.00141	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000216	0.00135	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000215	0.00134	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000212	0.00132	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NAT2—urinary bladder cancer	0.000211	0.00132	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000209	0.00131	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000206	0.00129	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NAT2—urinary bladder cancer	0.000204	0.00128	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000203	0.00127	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000197	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.000197	0.00123	CbGpPWpGaD
Tolbutamide—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000194	0.00122	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	0.000192	0.0012	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000192	0.0012	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000189	0.00118	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000188	0.00117	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—RRM2—urinary bladder cancer	0.000182	0.00114	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TYMP—urinary bladder cancer	0.000181	0.00113	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—RRM2—urinary bladder cancer	0.000176	0.0011	CbGpPWpGaD
Tolbutamide—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000176	0.0011	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000175	0.00109	CbGpPWpGaD
Tolbutamide—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000174	0.00109	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000172	0.00108	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ENO2—urinary bladder cancer	0.000168	0.00105	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—HPGDS—urinary bladder cancer	0.000168	0.00105	CbGpPWpGaD
Tolbutamide—SLCO2B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000164	0.00103	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NAT2—urinary bladder cancer	0.000164	0.00103	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTT1—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ENO2—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—HPGDS—urinary bladder cancer	0.000163	0.00102	CbGpPWpGaD
Tolbutamide—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.00016	0.001	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTT1—urinary bladder cancer	0.000158	0.00099	CbGpPWpGaD
Tolbutamide—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000158	0.00099	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000154	0.000964	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	0.000154	0.000961	CbGpPWpGaD
Tolbutamide—ABCC8—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000153	0.000956	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000148	0.000923	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—RRM2—urinary bladder cancer	0.000142	0.000885	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	0.000139	0.000869	CbGpPWpGaD
Tolbutamide—SLC15A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000138	0.000861	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NQO1—urinary bladder cancer	0.000136	0.000848	CbGpPWpGaD
Tolbutamide—ABCC8—Neuronal System—HRAS—urinary bladder cancer	0.000133	0.000829	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NQO1—urinary bladder cancer	0.000132	0.000823	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000131	0.000822	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—HPGDS—urinary bladder cancer	0.000131	0.00082	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ENO2—urinary bladder cancer	0.000131	0.00082	CbGpPWpGaD
Tolbutamide—KCNJ11—Neuronal System—HRAS—urinary bladder cancer	0.000128	0.000804	CbGpPWpGaD
Tolbutamide—SLC15A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000128	0.000799	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTT1—urinary bladder cancer	0.000127	0.000795	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.000125	0.000779	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.000125	0.000779	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000123	0.000766	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	0.00012	0.00075	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000117	0.000734	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	0.000114	0.000713	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTP1—urinary bladder cancer	0.000113	0.000708	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000111	0.000696	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000111	0.000696	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	0.000111	0.000695	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	0.000111	0.000695	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.00011	0.000691	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTP1—urinary bladder cancer	0.00011	0.000686	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000109	0.000684	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	0.000108	0.000674	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000107	0.000669	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000106	0.000663	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NQO1—urinary bladder cancer	0.000106	0.000661	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—TYMS—urinary bladder cancer	0.000105	0.000658	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GSTM1—urinary bladder cancer	0.000104	0.00065	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—NCOR1—urinary bladder cancer	0.000104	0.00065	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	0.000103	0.000642	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—TYMS—urinary bladder cancer	0.000102	0.000638	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000102	0.000636	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000101	0.000634	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000101	0.000634	CbGpPWpGaD
Tolbutamide—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000101	0.000631	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—NCOR1—urinary bladder cancer	0.000101	0.000631	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GSTM1—urinary bladder cancer	0.000101	0.000631	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.97e-05	0.000624	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—GPX1—urinary bladder cancer	9.96e-05	0.000623	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—ERCC2—urinary bladder cancer	9.78e-05	0.000611	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	9.69e-05	0.000606	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—GPX1—urinary bladder cancer	9.66e-05	0.000604	CbGpPWpGaD
Tolbutamide—SLC22A6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.48e-05	0.000593	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—ERCC2—urinary bladder cancer	9.48e-05	0.000593	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	9.44e-05	0.000591	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	9.28e-05	0.00058	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—MTHFR—urinary bladder cancer	9.19e-05	0.000575	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	9.16e-05	0.000573	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	8.95e-05	0.00056	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—MTHFR—urinary bladder cancer	8.91e-05	0.000557	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTP1—urinary bladder cancer	8.82e-05	0.000551	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.69e-05	0.000543	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.65e-05	0.000541	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.43e-05	0.000527	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	8.35e-05	0.000522	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—TYMS—urinary bladder cancer	8.2e-05	0.000513	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—NCOR1—urinary bladder cancer	8.1e-05	0.000507	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GSTM1—urinary bladder cancer	8.1e-05	0.000507	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.89e-05	0.000493	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—GPX1—urinary bladder cancer	7.76e-05	0.000485	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.69e-05	0.000481	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—ERCC2—urinary bladder cancer	7.62e-05	0.000476	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.58e-05	0.000474	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.57e-05	0.000474	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TYMP—urinary bladder cancer	7.55e-05	0.000472	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	7.47e-05	0.000467	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PPARG—urinary bladder cancer	7.45e-05	0.000466	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.25e-05	0.000453	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PPARG—urinary bladder cancer	7.23e-05	0.000452	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.22e-05	0.000452	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—MTHFR—urinary bladder cancer	7.16e-05	0.000448	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—CREBBP—urinary bladder cancer	7.16e-05	0.000448	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	6.94e-05	0.000434	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—CREBBP—urinary bladder cancer	6.94e-05	0.000434	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	6.86e-05	0.000429	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	6.86e-05	0.000429	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NAT2—urinary bladder cancer	6.83e-05	0.000427	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.76e-05	0.000423	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.74e-05	0.000421	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	6.57e-05	0.000411	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.47e-05	0.000405	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	6.45e-05	0.000403	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.16e-05	0.000385	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TYMP—urinary bladder cancer	6.14e-05	0.000384	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.09e-05	0.000381	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	6.06e-05	0.000379	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.9e-05	0.000369	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.89e-05	0.000369	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTGS2—urinary bladder cancer	5.86e-05	0.000367	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PPARG—urinary bladder cancer	5.81e-05	0.000363	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTGS2—urinary bladder cancer	5.68e-05	0.000356	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—CREBBP—urinary bladder cancer	5.58e-05	0.000349	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.56e-05	0.000348	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	5.46e-05	0.000341	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ENO2—urinary bladder cancer	5.46e-05	0.000341	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.43e-05	0.000339	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.29e-05	0.000331	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.26e-05	0.000329	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.21e-05	0.000326	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—PTEN—urinary bladder cancer	5.11e-05	0.00032	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—PTEN—urinary bladder cancer	4.96e-05	0.00031	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	4.92e-05	0.000308	CbGpPWpGaD
Tolbutamide—ABCC8—Metabolism—EP300—urinary bladder cancer	4.88e-05	0.000305	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.87e-05	0.000305	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.87e-05	0.000305	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.84e-05	0.000303	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.8e-05	0.0003	CbGpPWpGaD
Tolbutamide—KCNJ11—Metabolism—EP300—urinary bladder cancer	4.73e-05	0.000296	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.73e-05	0.000296	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	4.72e-05	0.000295	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.65e-05	0.000291	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTGS2—urinary bladder cancer	4.57e-05	0.000286	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.44e-05	0.000278	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.44e-05	0.000278	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.42e-05	0.000276	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.4e-05	0.000275	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.31e-05	0.000269	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.27e-05	0.000267	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.24e-05	0.000265	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—PTEN—urinary bladder cancer	3.98e-05	0.000249	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.93e-05	0.000246	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	3.87e-05	0.000242	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.81e-05	0.000238	CbGpPWpGaD
Tolbutamide—CYP2C18—Metabolism—EP300—urinary bladder cancer	3.8e-05	0.000238	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.72e-05	0.000233	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.67e-05	0.000229	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.58e-05	0.000224	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.55e-05	0.000222	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.47e-05	0.000217	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.41e-05	0.000213	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	3.37e-05	0.000211	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.37e-05	0.000211	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.37e-05	0.000211	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.32e-05	0.000208	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.28e-05	0.000205	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.23e-05	0.000202	CbGpPWpGaD
Tolbutamide—SLCO1A2—Metabolism—EP300—urinary bladder cancer	3.22e-05	0.000201	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.17e-05	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.17e-05	0.000198	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.04e-05	0.00019	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.03e-05	0.000189	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.01e-05	0.000188	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.01e-05	0.000188	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.99e-05	0.000187	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.98e-05	0.000186	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.89e-05	0.000181	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.88e-05	0.00018	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.83e-05	0.000177	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.78e-05	0.000174	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.74e-05	0.000172	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.74e-05	0.000172	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.66e-05	0.000166	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.63e-05	0.000164	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.58e-05	0.000161	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.43e-05	0.000152	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.42e-05	0.000151	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.32e-05	0.000145	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.16e-05	0.000135	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.07e-05	0.00013	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.97e-05	0.000123	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.9e-05	0.000119	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.89e-05	0.000118	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.7e-05	0.000106	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.66e-05	0.000104	CbGpPWpGaD
Tolbutamide—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.58e-05	9.89e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.55e-05	9.68e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.48e-05	9.25e-05	CbGpPWpGaD
Tolbutamide—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.41e-05	8.83e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.35e-05	8.44e-05	CbGpPWpGaD
Tolbutamide—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.29e-05	8.05e-05	CbGpPWpGaD
